Zouina Sarfraz, Postdoctoral Research Fellow in Oncology at the Miami Cancer Institute, shared a post on X:
“A much-needed end to a wonderful 2025. Pleased to share our BMC cancer (BMC Series) publication on the TUTOR Phase 1 trial evaluating tucatinib + trastuzumab + capecitabine with SRS for HER2+ breast cancer brain metastases Grateful to Dr. Ahluwalia (Manmeet Ahluwalia) for his leadership and mentorship, and to the entire author team for their collaboration.”
Title: Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial
Authors: Zouina Sarfraz, Ahmad Ozair, Mainak Bardhan, Amy K. Starosciak, Dilanis C. Perche, Lydia C. Hodgson, Yazmin Odia, Minesh P. Mehta, Rupesh Kotecha, Michael W. McDermott, Arun Maharaj, Ana Cristina Sandoval Leon, Reshma Mahtani, Manmeet S. Ahluwalia
Read The Full Article.
More posts from Zouina Sarfraz on OncoDaily.